Electroacupuncture for Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: Study Protocol for a Randomised Controlled Trial

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Jul 20

PMID 39032929

Authors

Lili Zhu

Yan Yan

Jinna Yu

Yan Liu

Yuanjie Sun

Yu Chen

Jiufei Fang

Zhishun Liu

Affiliations

Soon will be listed here.

Abstract

Introduction: Benign prostatic hyperplasia (BPH) is a condition commonly seen among men aged over 40, significantly affecting their quality of life and typically accompanied by lower urinary tract symptoms (LUTS). Acupuncture presents a potentially effective treatment option; however, the exact effects remain uncertain. Therefore, we design this multicentre randomised trial to evaluate the efficacy and safety of electroacupuncture (EA) for relieving LUTS in men with BPH.

Methods And Analysis: A two-arm, sham-controlled, subject-blinded and assessor-blinded trial will be conducted in 11 hospitals in China to compare EA with sham electroacupuncture (SA) in treating moderate to severe LUTS of BPH among men aged 40-80. A total of 306 eligible male patients will be recruited and assigned at a 1:1 ratio to receive either EA or SA for 24 sessions over a succession of 8 weeks, with 24 weeks of follow-up. The primary outcome will be the proportions of participants with at least 30% reduction in the International Prostate Symptom Score total score from baseline at weeks 8 and 20. All statistical analyses will be conducted in accordance with the intention-to-treat principle, and a two-tailed p value less than 0.05 will be considered statistically significant.

Ethics And Dissemination: The trial has been approved by the institutional review board of Guang'anmen Hospital (2022-203-KY), as well as other recruitment centres. Each participant will receive the detailed information of the trial, and sign the written informed consent. The results of the trial are expected to be published in a peer-reviewed journal.

Trial Registration Number: NCT05585450.

References

Reynard J, Yang Q, Donovan J, Peters T, Schafer W, de la Rosette J . The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol. 1998; 82(5):619-23. DOI: 10.1046/j.1464-410x.1998.00813.x. View

Lerner L, McVary K, Barry M, Bixler B, Dahm P, Das A . Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol. 2021; 206(4):806-817. DOI: 10.1097/JU.0000000000002183. View

Batista-Miranda J, Diez M, Bertran P, Villavicencio H . Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions. Pharmacoeconomics. 2001; 19(11):1079-90. DOI: 10.2165/00019053-200119110-00002. View

Paterson C, Dieppe P . Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ. 2005; 330(7501):1202-5. PMC: 558023. DOI: 10.1136/bmj.330.7501.1202. View

Chang P . Urodynamic studies in acupuncture for women with frequency, urgency and dysuria. J Urol. 1988; 140(3):563-6. DOI: 10.1016/s0022-5347(17)41719-8. View

Liu X, Liu K, Zhi M, Mo Q, Gao X, Liu Z . Effects of electroacupuncture at BL33 on detrusor smooth muscle activity in a rat model of urinary retention. Acupunct Med. 2017; 35(6):437-444. PMC: 5738530. DOI: 10.1136/acupmed-2016-011355. View

Langan R . Benign Prostatic Hyperplasia. Prim Care. 2019; 46(2):223-232. DOI: 10.1016/j.pop.2019.02.003. View

Yokoyama O, Hiro S, Hotta S, Mogami S, Yamagami H . Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder. Urology. 2014; 83(4):750-5. DOI: 10.1016/j.urology.2013.12.008. View

Liu B, Liu Y, Qin Z, Zhou K, Xu H, He L . Electroacupuncture Versus Pelvic Floor Muscle Training Plus Solifenacin for Women With Mixed Urinary Incontinence: A Randomized Noninferiority Trial. Mayo Clin Proc. 2019; 94(1):54-65. DOI: 10.1016/j.mayocp.2018.07.021. View

10.

Foo K . Pathophysiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017; 4(3):152-157. PMC: 5717988. DOI: 10.1016/j.ajur.2017.06.003. View

11.

Gandhi S, Gajewski J, Koziarz A, Almutairi S, Ali A, Cox A . Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23-year experience. Neurourol Urodyn. 2020; 40(1):461-469. DOI: 10.1002/nau.24583. View

12.

Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P . Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008; 180(1):246-9. DOI: 10.1016/j.juro.2008.03.058. View

13.

Li M, Lv J, Zhao L, Niu H . [Different needling depth for benign prostatic hyperplasia: a randomized controlled trial]. Zhongguo Zhen Jiu. 2020; 40(10):1071-5. DOI: 10.13703/j.0255-2930.20190923-0001. View

14.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

15.

Hollingsworth J, Wilt T . Lower urinary tract symptoms in men. BMJ. 2014; 349:g4474. PMC: 4688452. DOI: 10.1136/bmj.g4474. View

16.

Van Asseldonk B, Barkin J, Elterman D . Medical therapy for benign prostatic hyperplasia: a review. Can J Urol. 2015; 22 Suppl 1:7-17. View

17.

Idzenga T, Pel J, van Mastrigt R . Accuracy of maximum flow rate for diagnosing bladder outlet obstruction can be estimated from the ICS nomogram. Neurourol Urodyn. 2007; 27(1):97-8. DOI: 10.1002/nau.20480. View

18.

Wang W, Guo Y, Zhang D, Tian Y, Zhang X . The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys. Sci Rep. 2015; 5:13546. PMC: 4549711. DOI: 10.1038/srep13546. View

19.

Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L . Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. JAMA. 2017; 317(24):2493-2501. PMC: 5815072. DOI: 10.1001/jama.2017.7220. View

20.

Peters K, Carrico D, Burks F . Validation of a sham for percutaneous tibial nerve stimulation (PTNS). Neurourol Urodyn. 2008; 28(1):58-61. DOI: 10.1002/nau.20585. View